SHANNON COLIN

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings

Download results Settings

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other

Notification date	Transaction date	Company	B/S Transaction type	Nb. shares Price Value	Number of shares	Price	Value
2021-06-21	2021-06-17	PRA Health Sciences Inc (PRAH)	PlS Planned sale	79,270 +20.1% 378.08 US$2,268,519	79,270 +20.1%	378.08	US$2,268,519
2021-06-21	2021-06-17	PRA Health Sciences Inc (PRAH)	PlS Planned sale	96,668 -32.6% 298.51 US$3,457,833	96,668 -32.6%	298.51	US$3,457,833
2021-06-21	2021-06-17	PRA Health Sciences Inc (PRAH)	PlS Planned sale	13,725 +27.6% 347.33 US$1,723,263	13,725 +27.6%	347.33	US$1,723,263
2021-06-21	2021-06-17	PRA Health Sciences Inc (PRAH)	PlS Planned sale	920 -0.2% 166.89 US$153,539	920 -0.2%	166.89	US$153,539
2020-08-17	2020-08-13	PRA Health Sciences Inc (PRAH)	S Sale	6,073 -9.6% 102.88 US$624,790	6,073 -9.6%	102.88	US$624,790
2004-07-22	2004-07-22	Pharmaceutical Product Development Inc (PPDI)	S Sale	1,628 -100.0% 34.98 US$56,947	1,628 -100.0%	34.98	US$56,947
2004-07-22	2004-07-22	Pharmaceutical Product Development Inc (PPDI)	S Sale	3,000 -64.8% 34.97 US$104,910	3,000 -64.8%	34.97	US$104,910